stars 1 stars 2 stars 3

About ProteoTech: ProteoTech is a private drug development company located in the Seattle, WA area (Kirkland, WA), and is focused on targeting amyloid diseases caused by protein misfolding. Besides the Company's Synuclere™ program, in late pre-clinical development for the treatment of Parkinson's disease, ProteoTech is developing Exebryl-1® for the treatment of diseases caused by beta-amyloid protein and tau protein aggregates and fibrils; and is in early human clinical studies with Systebryl™ for the treatment of Systemic AA Amyloidosis. The Company is also in late pre-clinical development for a novel small peptide (PepticlereTM) for the treatment of Alzheimer's disease beta-amyloid protein aggregates.

Website http://www.yelp.com/biz/proteotech-kirkland
Revenue $6.5 million
Employees 4 (0 on RocketReach)
Founded 1996
Address 12040 115th Avenue NE, Kirkland, Washington 98034, US
Phone +1 425-823-8508
Industry Drug Stores & Pharmacies, Biotechnology, Drug Discovery, Retail, Science and Engineering, Other Pharmaceuticals and Biotechnology, Health Diagnostics, Health Care, Therapeutics
SIC SIC Code 2834 Companies, SIC Code 873 Companies, SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 283 Companies
NAICS NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies

ProteoTech Inc. Questions

The ProteoTech Inc. annual revenue was $6.5 million in 2026.

ProteoTech Inc. is based in Kirkland, Washington.

The NAICS codes for ProteoTech Inc. are [325, 32541, 3254, 541, 54, 32].

The SIC codes for ProteoTech Inc. are [2834, 873, 87, 28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users